Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    548 - 1. Can a modified intent-to-treat (mITT) analysis be used in promotional materials? mITT analysis excluded patients who discontinued due to adverse event, lost to follow-up, or subject withdrawal. 2. If yes, would also need to show the primary endpoint analysis, ITT, as shown in the PM? 3. Are there any specific requirements on how the primary ITT and mITT analyses need to be displayed?

    Claims & Support/References for Claims
    1
    1
    60
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      Claims supported by a superiority trial should be based on ITT. This means that all patients who were enrolled & randomly allocated to treatment are included in the analysis and are analysed in the groups to which they were randomized.

      Note that mITT, by definition, is a deviation from ITT. It should not be used as the basis/evidence for a claim.

      1 Reply Last reply Reply Quote 0
      • First post
        Last post